Citations (27)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Julius Fink, Brad Jon Schoenfeld, Anthony C. Hackney, Masahito Matsumoto, Takahiro Maekawa, Koichi Nakazato & Shigeo Horie. (2019) Anabolic-androgenic steroids: procurement and administration practices of doping athletes. The Physician and Sportsmedicine 47:1, pages 10-14.
Read now
Read now
Articles from other publishers (26)
Celine Vanhee, Bram Jacobs, Marcella Mori, Angélique Kamugisha, Loïc Debehault, Michael Canfyn, Bart Ceyssens, Hans Van Der Meersch, Koenraad van Hoorde, Eric Deconinck & Marie Willocx. (2023) Uncovering the Quality Deficiencies with Potentially Harmful Effects in Substandard and Falsified PDE-5 Inhibitors Seized by Belgian Controlling Agencies. Forensic Sciences 3:3, pages 426-451.
Crossref
Crossref
Pia Johansson Heinsvig, Ask Vest Christiansen, Daniel Ayoubi, Laura Smedegaard Heisel & Christian Lindholst. (2023) Do you get what you see? The illicit doping market in Denmark—An analysis of performance and image enhancing drugs seized by the police over a 1‐year period. Drug Testing and Analysis 15:6, pages 668-677.
Crossref
Crossref
Muriel Kruijver, Philip Bruggmann & Raphael Magnolini. (2023) Evidence of use and users of image- and performance-enhancing drugs in sports in Switzerland: a scoping literature review and implications for Swiss drug policy. Swiss Medical Weekly 153:5, pages 40080.
Crossref
Crossref
Pooja Dhurjad, Pooja Jaiswal, Kajal Gupta, Parita Wanjari & Rajesh Sonti. (2022) Mass spectrometry: A key tool in anti‐doping. SEPARATION SCIENCE PLUS 6:2.
Crossref
Crossref
Raphael Magnolini, Luis Falcato, Alessio Cremonesi, Dominique Schori & Philip Bruggmann. (2022) Fake anabolic androgenic steroids on the black market – a systematic review and meta-analysis on qualitative and quantitative analytical results found within the literature. BMC Public Health 22:1.
Crossref
Crossref
Diederik L. Smit, Aldo Grefhorst, Madelon M. Buijs, Olivier Hon, Martin Heijer & Willem Ronde. (2022) Prospective study on blood pressure, lipid metabolism and erythrocytosis during and after androgen abuse. Andrologia 54:4.
Crossref
Crossref
Lucas Moraes Berneira, Tais Poletti, Samantha Coelho de Freitas, Caroline Carapina da Silva, Rafael Scorsatto Ortiz & Claudio Martin Pereira de Pereira. (2021) Extraction and analytical approaches in the forensic evaluation of anabolic androgenic steroid formulations. WIREs Forensic Science 4:3.
Crossref
Crossref
Chloé Cloteau, Gaud Dervilly, Zied Kaabia, Florian Bagilet, Vivian Delcourt, Benoit Loup, Yann Guitton, Anne‐Lise Royer, Fabrice Monteau, Patrice Garcia, Marie‐Agnès Popot, Bruno Le Bizec & Ludovic Bailly‐Chouriberry. (2022) From a non‐targeted metabolomics approach to a targeted biomarkers strategy to highlight testosterone abuse in equine. Illustration of a methodological transfer between platforms and laboratories. Drug Testing and Analysis 14:5, pages 864-878.
Crossref
Crossref
Nadia Arbouche, Charline Bottinelli, Enrico Gerace & Laurie Gheddar. (2022) Interest of HRMS systems in analytical toxicology: Focus on doping products. Toxicologie Analytique et Clinique 34:1, pages 42-68.
Crossref
Crossref
Katarzyna Kowalczyk, Julio César Torres‐Elguera, Anna Jarek, Anna Konopka, Dorota Kwiatkowska & Ewa Bulska. (2021) In vitro metabolic studies of novel selective androgen receptor modulators and their use for doping control analysis. Drug Testing and Analysis 14:1, pages 122-136.
Crossref
Crossref
Lukáš Huml, Jan Tauchen, Silvie Rimpelová, Barbora Holubová, Oldřich Lapčík & Michal Jurášek. (2021) Advances in the Determination of Anabolic-Androgenic Steroids: From Standard Practices to Tailor-Designed Multidisciplinary Approaches. Sensors 22:1, pages 4.
Crossref
Crossref
Lena Ekström, Susanne Broström, Marja-Liisa Dahl & Annica Börjesson. (2021) A Summary of Online Enquiries Submitted to Anti-doping Hotline 2005–2018. Frontiers in Reproductive Health 3.
Crossref
Crossref
Ingrid Amalia Havnes & Ashley Elizabeth Muller. (2021) Nonprescribed androgen use among women and trans men. Current Opinion in Endocrinology, Diabetes & Obesity 28:6, pages 595-603.
Crossref
Crossref
Katja M. Shimko, Timothy Piatkowski, Kevin V. Thomas, Naomi Speers, Lance Brooker, Ben J. Tscharke & Jake W. O’Brien. (2021) Performance- and image-enhancing drug use in the community: use prevalence, user demographics and the potential role of wastewater-based epidemiology. Journal of Hazardous Materials 419, pages 126340.
Crossref
Crossref
Nicolas Fabresse, Laurie Gheddar, Pascal Kintz, Adeline Knapp, Islam Amine Larabi & Jean-Claude Alvarez. (2021) Analysis of pharmaceutical products and dietary supplements seized from the black market among bodybuilders. Forensic Science International 322, pages 110771.
Crossref
Crossref
D L Smit, M M Buijs, O de Hon, M den Heijer & W de Ronde. (2021) Disruption and recovery of testicular function during and after androgen abuse: the HAARLEM study. Human Reproduction 36:4, pages 880-890.
Crossref
Crossref
Diederik L. Smit, Madelon M. Buijs, Olivier Hon, Martin Heijer & Willem Ronde. (2020) Positive and negative side effects of androgen abuse. The HAARLEM study: A one‐year prospective cohort study in 100 men. Scandinavian Journal of Medicine & Science in Sports 31:2, pages 427-438.
Crossref
Crossref
Hagit Bonny-Noach, Ronny Berkovitz & Barak Shapira. (2020) Evaluation of performance-enhancing drugs seized by Israeli enforcement agencies 2012–2017: implications for policy and regulatory change. Israel Journal of Health Policy Research 9:1.
Crossref
Crossref
Evelyn Frude, Fiona H. McKay & Matthew Dunn. (2020) A focused netnographic study exploring experiences associated with counterfeit and contaminated anabolic-androgenic steroids. Harm Reduction Journal 17:1.
Crossref
Crossref
Dino Luethi & Matthias E. Liechti. (2020) Designer drugs: mechanism of action and adverse effects. Archives of Toxicology 94:4, pages 1085-1133.
Crossref
Crossref
Annica Börjesson, Mikael Lehtihet, Alexander Andersson, Marja‐Liisa Dahl, Veronica Vicente, Magnus Ericsson & Lena Ekström. (2020) Studies of athlete biological passport biomarkers and clinical parameters in male and female users of anabolic androgenic steroids and other doping agents. Drug Testing and Analysis 12:4, pages 514-523.
Crossref
Crossref
Diederik L. Smit, Olivier Hon, Bastiaan J. Venhuis, Martin den Heijer & Willem Ronde. (2019) Baseline characteristics of the HAARLEM study: 100 male amateur athletes using anabolic androgenic steroids. Scandinavian Journal of Medicine & Science in Sports 30:3, pages 531-539.
Crossref
Crossref
Lucas Moraes Berneira, Samantha Coelho de Freitas, Caroline Carapina da Silva, Alexandre de Mattos Machado, Claudio Martin Pereira de Pereira & Marco Aurélio Ziemann dos Santos. (2019) Application of differential scanning calorimetry in the analysis of apprehended formulations of anabolic androgenic steroids. Forensic Science International 296, pages 15-21.
Crossref
Crossref
Paulina Marta Gajda, Niels Bjerre Holm, Lars Jakobsen Hoej, Brian Schou Rasmussen, Petur Weihe Dalsgaard, Lotte Ask Reitzel & Kristian Linnet. (2019) Glycine-modified growth hormone secretagogues identified in seized doping material. Drug Testing and Analysis 11:2, pages 350-354.
Crossref
Crossref
Magdalena Popławska & Agata Błażewicz. (2019) Identification of a novel growth hormone releasing peptide (a glycine analogue of GHRP-2) in a seized injection vial. Drug Testing and Analysis 11:1, pages 162-167.
Crossref
Crossref
Steven Janvier, Bart De Spiegeleer, Celine Vanhee & Eric Deconinck. (2018) Falsification of biotechnology drugs: current dangers and/or future disasters?. Journal of Pharmaceutical and Biomedical Analysis 161, pages 175-191.
Crossref
Crossref